Oyster Point Pharma, Inc. Quarterly Return On Equity in % from Q4 2018 to Q3 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oyster Point Pharma, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2018 to Q3 2022.
  • Oyster Point Pharma, Inc. Return On Equity for the quarter ending September 30, 2022 was -490 %, a 881% decline year-over-year.
  • Oyster Point Pharma, Inc. annual Return On Equity for 2021 was -72 %, a 87.8% decline from 2020.
  • Oyster Point Pharma, Inc. annual Return On Equity for 2020 was -38.3 %, a 104% decline from 2019.
  • Oyster Point Pharma, Inc. annual Return On Equity for 2019 was 1.01K %, a 1810% increase from 2018.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2022 -490 -440 -881% Jul 1, 2022 Sep 30, 2022
Q2 2022 -207 -163 -367% Apr 1, 2022 Jun 30, 2022
Q1 2022 -117 -79.4 -214% Jan 1, 2022 Mar 31, 2022
Q4 2021 -72 -33.7 -87.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -50 -10.4 -26.2% Jul 1, 2021 Sep 30, 2021
Q2 2021 -44.4 +16.1 +26.6% Apr 1, 2021 Jun 30, 2021
Q1 2021 -37.2 +123 +76.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 -38.3 -1.05K -104% Oct 1, 2020 Dec 31, 2020
Q3 2020 -39.6 -102 -164% Jul 1, 2020 Sep 30, 2020
Q2 2020 -60.5 -121 -200% Apr 1, 2020 Jun 30, 2020
Q1 2020 -160 -209 -429% Jan 1, 2020 Mar 31, 2020
Q4 2019 1.01K +956 +1810% Oct 1, 2019 Dec 31, 2019
Q3 2019 62 Jul 1, 2019 Sep 30, 2019
Q2 2019 60.6 Apr 1, 2019 Jun 30, 2019
Q1 2019 48.8 Jan 1, 2019 Mar 31, 2019
Q4 2018 52.8 Oct 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.